# Intermittent Intravenous Levosimendan in Ambulatory Advanced Chronic Heart Failure Patients

> **NCT01536132** · PHASE4 · COMPLETED · sponsor: **Parc de Salut Mar** · enrollment: 70 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Levosimendan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01536132
- **Lead sponsor:** Parc de Salut Mar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-10
- **Final completion:** 2015-11
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2016-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01536132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01536132, "Intermittent Intravenous Levosimendan in Ambulatory Advanced Chronic Heart Failure Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01536132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*